Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

Share Price Information for De La Rue (DLAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 99.40
Bid: 98.20
Ask: 99.40
Change: 0.00 (0.00%)
Spread: 1.20 (1.222%)
Open: 99.60
High: 100.00
Low: 98.60
Prev. Close: 99.40
DLAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

29 Aug 2008 13:45

RNS Number : 3356C
De La Rue PLC
29 August 2008
 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

1. Name of Company

DE LA RUE PLC

2 & 3. Details of Transactions

NAME

TRANSACTION NOTIFIED IN ACCORDANCE WITH DR 3.1.4R

(1)(A) PDMR

(1)(B) DIRECTOR

LEO QUINN

YES

YES

STEPHEN KING

YES

YES

JANE VAN AMMEL 

YES

LOUISE FLUKER

YES

ANDREW VAUGHAN

YES

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

N/A

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest.

N/A

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares.

N/A

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them.

N/A

8. State the nature of the transaction.

N/A

9. Number of shares, debentures or financial instruments relating to shares acquired.

N/A

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage).

N/A

11. Number of shares, debentures or financial instruments relating to shares disposed.

N/A

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage).

N/A

13. Price per share or value of transaction.

N/A

14. Date and place of transaction.

N/A

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage).

N/A

16. Date issuer informed of transaction.

N/A

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17. Date of Allocation.

26 JUNE 2008

1 AUGUST 2008

18. Period during which or date on which it can be exercised.

AWARDS WILL VEST ON 26 JUNE 2011

19. Total amount paid (if any) for grant of the option.

NIL

20. Description of shares or debentures involved (class and number).

26 JUNE 2008 - DETAILS OF AWARD GRANTED

Deferred Allocation 

Ordinary Shares of 2916/21 each

Maximum Matching Allocation

Ordinary Shares of 2916/21 each

LEO QUINN

28,894

57,788

STEPHEN KING

12,336

24,671

JANE VAN AMMEL

4,246

6,369

LOUISE FLUKER

5,228

7,843

ANDREW VAUGHAN

3,610

5,416

1 AUGUST 2008 - DETAILS OF DIVIDEND SHARES IN RESPECT OF AWARD GRANTED 26 JUNE 2008 ONLY

LEO QUINN

509

ORDINARY SHARES OF 2916/21 P EACH

STEPHEN KING

217

ORDINARY SHARES OF 2916/21 P EACH

JANE VAN AMMEL

74

ORDINARY SHARES OF 2916/21 P EACH

LOUISE FLUKER

92

ORDINARY SHARES OF 2916/21 P EACH

ANDREW VAUGHAN

63

ORDINARY SHARES OF 2916/21 P EACH

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise.

Deferred Allocation price of 908.5p

Deferred dividend allocation in shares based on share price of 843.00 pence.

22. Total number of shares or debentures over which options held following notification.

LEO QUINN

667,704

STEPHEN KING

136,196

JANE VAN AMMEL

 44,078

LOUISE FLUKER

 55,519

ANDREW VAUGHAN

 19,357

23. Any additional information.

The deferred allocation is under the De LRue Deferred Bonus and Matching Share Plan ( the "Plan"). The matching allocation of shares will be made at the vesting date subject to performance testing in accordance with the Rules of the Plan.

An additional award of shares will be released on the vesting date in respect of deferred shares released equal in value to the amount of dividends which would have been payable on the deferred shares over the performance period

Total options reported under 22 above inclusive of maximum matching shares which are subject to performance condition being met.

Allocations under this Plan were made to other eligible employees on 26 June 2008. The individuals referred to in disclosure 2 & 3 were initially not included as recipients of allocations. Pursuant to a resolution of the Board dated 28 August 2008 the Board concluded it would be appropriate to include them within the Plan on the same terms and conditions applicable to other recipients of allocations. Consequently the allocation price of £9.085 (Disclosure 21) applicable to allocations on 26 June 2008 has been applied rather than the mid-market price of £815.5 on 20 August 2008.

The Board also decided that the individuals should be eligible for an additional deferred allocation equal in value to the amount of dividends which would have been payable only on the deferred shares allocated on 26 June 2008 under the following payment of the interim dividend on 1 August 2008. (Detailed in table two of Disclosure 20).

24. Name of contact and telephone number for queries

LOUISE FLUKER, GENERAL COUNSEL & COMPANY SECRETARY - 01256 605311

29 AUGUST 2008

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAAPNALDPEFE
Date   Source Headline
27th Jun 20243:48 pmRNSHolding(s) in Company
30th May 20247:00 amRNSStrategic Update
2nd May 202411:39 amRNSHolding(s) in Company
17th Apr 20247:00 amRNSPre-Close Trading Statement
16th Apr 202411:52 amRNSHolding(s) in Company
16th Apr 202410:59 amRNSHolding(s) in Company
3rd Apr 20247:00 amRNSExtension of contract with Microsoft
2nd Apr 202411:25 amRNSTotal Voting Rights
7th Mar 20241:04 pmRNS2023 AGM Voting Update
23rd Feb 20242:06 pmRNSAdditional Listing
29th Jan 20244:14 pmRNSHolding(s) in Company
26th Jan 20244:38 pmRNSDirector/PDMR Shareholding
18th Jan 20243:19 pmRNSHolding(s) in Company
18th Jan 202412:13 pmRNSHolding(s) in Company
2nd Jan 202411:33 amRNSBlock listing Interim Review
21st Dec 20233:51 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNS2023/24 half year results
27th Nov 20232:53 pmRNSHolding(s) in Company
1st Nov 20231:51 pmRNSTotal Voting Rights
30th Oct 202311:05 amRNSHolding(s) in Company
13th Oct 202310:27 amRNSDirector/PDMR Shareholding
6th Oct 20237:00 amRNSPre-close Trading Statement
2nd Oct 202311:47 amRNSTotal Voting Rights
20th Sep 202312:59 pmRNSDirector/PDMR Shareholding
13th Sep 20231:09 pmRNSHolding(s) in Company
7th Sep 20231:59 pmRNSResult of AGM
7th Sep 20237:00 amRNSAGM statement and trading update
4th Sep 202312:36 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
14th Aug 20233:30 pmRNSHolding(s) in Company
11th Aug 20232:58 pmRNSHolding(s) in Company
11th Aug 20237:00 amRNSDirectorate Change
4th Aug 20237:00 amRNSDirectorate Change
3rd Aug 20239:21 amRNSAppointment of Joint Broker
2nd Aug 20233:26 pmRNSDirector/PDMR Shareholding
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 20231:44 pmRNSDirector/PDMR Shareholding
24th Jul 20233:04 pmRNSHolding(s) in Company
20th Jul 20234:03 pmRNSHolding(s) in Company
20th Jul 202312:17 pmRNSAnnual Financial Report
19th Jul 20231:01 pmRNSHolding(s) in Company
11th Jul 202310:28 amRNSDirector/PDMR Shareholding
4th Jul 202312:59 pmRNSHolding(s) in Company
3rd Jul 20235:44 pmRNSHolding(s) in Company
3rd Jul 202312:12 pmRNSBlock listing Interim Review
3rd Jul 202312:09 pmRNSTotal Voting Rights
30th Jun 20231:40 pmRNSHolding(s) in Company
30th Jun 20231:35 pmRNSHolding(s) in Company
30th Jun 202310:11 amRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSFY23 full year results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.